UNSPSC 51432106: Guanoclor

This classification denotes an antihypertensive agent with the molecular formula C9H12Cl2N4O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M4HBT852YO, chemically known as 2-(2,6-dichlorophenoxy)ethylaminoguanidine sulfate but generally known as guanoclor, which bears US NIH Compound Identifier 71835. European Medicines Agency schedules Guanoclor in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07987MIG.

UNSPSC 51432106 Guanoclor is a Commodity code that covers pharmaceutical preparations used in emergency medical and health-system applications. State and local governments procure under this code primarily through emergency services departments, health agencies, and cooperative purchasing alliances seeking generic and specialized medications for trauma response, critical care, and public-health programs. The work involves supplying finished pharmaceutical products—typically in injectable or oral form—to fire rescue services, health and human services agencies, and multi-jurisdictional purchasing consortia, with vendors responsible for maintaining expiration dates, arranging logistics and replacement of expired stock, and complying with FDA manufacturing standards, OSHA safety documentation, and supply-chain security requirements.

Recent activity shows issuing bodies spanning municipal fire departments, state health agencies, and multi-state cooperative purchasing vehicles. The City of Tampa's Purchasing Department posted an IFB in April 2026 for Advanced Life Support Medications (Solicitation 26P00188, due April 8, 2026) supplying epinephrine, labetalol, adenosine, and diltiazem vials to Tampa Fire Rescue with a one-year term and estimated value of $40,000, with a 5 percent small local business enterprise bid discount available. The Texas Health and Human Services Commission issued an RFI in April 2026 exploring direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, solicited RFP responses due March 26, 2026, for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities in Minnesota and Oregon through authorized wholesalers, with contract effectiveness July 1, 2026. Procurement activity concentrates in Texas, Minnesota, Florida, and Oregon, with multi-state cooperative purchasing vehicles emerging as significant buyers consolidating demand across multiple jurisdictions.